Stock Analiz

CG Oncology, Inc. (CGON) stock forecast and price target

Price $74.40 · data as of November 13, 2026

12-month price target

Average target$92.15
Upside / downside+23.9%
Analysts13
ConsensusStrong buy
Low $80.00Average $92.15High $112.00

Gold marker: average target · white marker: today’s price ($74.40)

Analyst ratings

Strong buy 4Buy 9Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.93−40.9%$5M
Next fiscal year
ends December 31, 2027
$-2.88+1.8%$95M
Next quarter
ends December 31, 2026
$-0.71−38.6%$727000
Quarter after
ends March 31, 2027
$-0.74−3.8%$400000

Consensus of the analysts covering CG Oncology, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the CG Oncology stock price target?

The average 12-month target from 13 analysts is $92.15, 23.9% above the current price of $74.40 Targets range from $80.00 to $112.00.

Is CG Oncology a buy according to analysts?

The consensus rating is “Strong buy” (4 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is CG Oncology expected to earn?

Analysts expect EPS of $-2.93 for the fiscal year ending December 31, 2026 and $-2.88 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.